Also from this source

You just read:

ITG's Majestic Market Research Prostate Cancer Study Indicates Amgen's Xgeva is Poised to Steal Significant Share From Novartis' Zometa; Physicians Still on the Fence About Dendreon's Provenge

News provided by

ITGMMR

Mar 22, 2011, 04:15 ET